IP Library Granted Patent US 8,119,399
Granted Patent B2
US 8,119,399 · App. 11/610,395 · Granted Feb 21, 2012

Method and system for collecting cells of a biological specimen

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,399
App. No.
11/610,395
Granted
Feb 21, 2012
Kind
B2
Abstract

A method for determining when sufficient cells of a biological specimen have been collected by a filter is based on measuring an air flow rate between a filter and a vacuum source. The air flow rate can be measured by a mass air flow sensor. The air flow rate dropping below a threshold, such as a certain percentage of an initial or baseline flow rate, indicates that sufficient cells have been collected to provide sufficient filter coverage.

Claims (23)

1. A method of collecting cells on a filter disposed in a specimen fluid containing suspended cells of a biological specimen, the method comprising:

applying a vacuum across the filter disposed in the specimen fluid using a vacuum source, thereby collecting specimen cells from the fluid on a surface of the filter;

measuring a rate of air flow between the filter and the vacuum source while the vacuum is being applied; and

determining when a sufficient amount of cells have been collected on the filter based on the measured air flow rate.

2. The method of claim 1 , wherein the applied vacuum is substantially constant.

3. The method of claim 1 , wherein the air flow rate is measured using a mass air flow sensor.

4. The method of claim 3 , wherein the mass air flow sensor is positioned between the filter and a valve that controls application of the vacuum.

5. The method of claim 3 , wherein the mass air flow sensor is positioned between the vacuum source and a valve that controls application of the vacuum, the valve being located between the mass air flow sensor and the filter.

6. The method of claim 1 , wherein determining whether sufficient cells have been collected on the filter comprises determining when the measured air flow rate drops below a threshold air flow rate.

7. The method of claim 6 , wherein the threshold air flow rate is determined relative to a baseline air flow rate.

8. The method of claim 7 , wherein the threshold air flow rate is about 80% of the baseline air flow rate.

9. The method of claim 7 , wherein about 20% of the filter surface is covered with specimen cells when the measured air flow rate is about 80% of the baseline air flow rate.

10. The method of claim 7 , wherein the baseline air flow rate is determined by measuring an air flow rate across the filter while the filter is suspended in a portion of the specimen fluid that is substantially free of cells.

11. A method of collecting cells on a filter disposed in a specimen fluid containing suspended cells of a biological specimen, the method comprising:

determining a baseline air flow rate between the filter and the vacuum source while the filter is suspended in a portion of the specimen fluid that contains relatively few, if any, suspended cells;

applying a vacuum across the filter disposed in the specimen fluid using a vacuum source, thereby collecting specimen cells from the specimen fluid on a distal facing surface of the filter;

monitoring a rate of air flow between the filter and the vacuum source while the vacuum is being applied; and

determining when a sufficient amount of cells have been collected on the filter based on the monitored air flow rate dropping below the baseline air flow rate by a predetermined amount.

12. The method of claim 11 , wherein the predetermined amount is about 80% of the determined baseline air flow rate.

13. The method of claim 12 , wherein about 20% of the filter surface is covered with cells when the monitored air flow rate is about 80% of the baseline air flow rate.

14. The method of claim 11 , wherein the applied vacuum is substantially constant.

15. The method of claim 11 , wherein the air flow rate is monitored using a mass air flow sensor positioned between the filter and a valve that controls application of the vacuum.

16. The method of claim 11 , wherein the air flow rate is monitored using mass air flow sensor positioned between the vacuum source and a valve that controls application of the vacuum, the valve being located between the mass air flow sensor and the filter.

Assignments (6)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →